Skip to main content
Clinical Trials/NCT01109862
NCT01109862
Unknown
Phase 1

Prospective Randomized Comparison of Bipolar Hemiarthroplasty and Total Hip Arthroplasty With Large Femoral Heads for the Treatment of Displaced Intracapsular Femoral Neck Fractures in the Elderly

Wolfson Medical Center1 site in 1 country80 target enrollmentApril 2010

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Femoral Neck Fractures
Sponsor
Wolfson Medical Center
Enrollment
80
Locations
1
Primary Endpoint
Oxford hip score (OHS)
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to compare hemiarthroplasty (HAP) with total hip arthroplasty (THA), performed by trained arthroplasty surgeons with the use of large femoral heads for the treatment of displaced femoral neck fractures in mobile independent elderly patients, to determine the impact of these surgical options on the short term functional outcomes and complication rates, namely dislocation and the need for further surgery.

This is a single-blinded prospective randomized clinical trial comparing functional outcome and complication rates of 40 patients treated with all cemented THA to a control group of 40 patients treated with cemented bipolar HAP, in a 2 years followup.

The primary endpoint is the Oxford hip score (OHS) at last followup as a measure of functional outcome. Secondary endpoints include the SF-36 score, walking distance and rates of postoperative dislocation, component loosening, need for revision and postoperative mortality.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
December 2013
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Acute femoral neck fracture.
  • Age between 70 and 90 years old.
  • Independent community ambulator (more than 0.5km, without the aid of another person. The use of a cane is permitted) prior to fracture.
  • Abbreviated mental test score \> 6 .

Exclusion Criteria

  • Pathological fracture (excluding osteoporosis).
  • Rheumatoid arthritis.
  • Symptomatic arthrosis of the involved hip.
  • Neurological disorder that may significantly influence walking ability and/or tendency to dislocate.
  • Chronic corticosteroid use.
  • Concomitant other fracture.
  • Very high surgical risk.

Outcomes

Primary Outcomes

Oxford hip score (OHS)

Time Frame: last followup - 2 years

Secondary Outcomes

  • SF-36 score, walking distance(2 years followup)
  • dislocation rate, mortality rate(within follow up - 2 years)

Study Sites (1)

Loading locations...

Similar Trials